Bausch Health Companies Inc. (BHC)
Drug Manufacturers - Specialty & Generic · Healthcare · $1.8B
Intrinsic Value (Consensus)
$9.86
Current Price
$4.78
Margin of Safety
+106.3%
106.3% Below Intrinsic Value
Value: $10
Price: $5
Valuation Model Estimates
Current Price: $4.78
DCF (Discounted Cash Flow)
$4.70
Graham Number
Not applicable
—
Earnings Power Value
$3.45
Relative Value (P/E)
$8.40
Dividend Discount Model
$22.89
Consensus Value
$9.86
Model Assumptions
Discount Rate
10.3%
Growth Rate
6.6%
Terminal Growth
2.5%
Risk-Free Rate
4.3%
Discount rate derived from CAPM (risk-free rate + beta × market risk premium). Growth rate based on trailing earnings growth, capped at 20%.
Health Score
C
62
Profitability
10/25
Strength
17/25
Valuation
22/25
Growth
13/25
Financial Health Signals
Solid dividend yield (15.2%)
High free cash flow yield (56.2%) — generating lots of cash relative to price
Key Financials
- EPS (TTM)
- $0.42
- EPS (Forward)
- $0.44
- Book Value
- $-1.48
- P/E Ratio
- 20.0
- Forward P/E
- 19.0
- PEG Ratio
- —
- ROE
- N/A
- Debt/Equity
- —
- Revenue Growth
- 6.7%
- Earnings Growth
- 6.6%
- Dividend Yield
- 15.2%
- Beta
- 1.31
Similar Stocks (Healthcare)
ABEOAbeona Therapeutics ...
$37.06+300%
ABUSArbutus Biopharma Co...
$18.93+300%
ADVBAdvanced Biomed Inc....
$26.66+300%
AGENAgenus Inc.
$20.19+300%
ATRAAtara Biotherapeutic...
$41.43+300%
Data last updated: 2026-06-21
Source: Yahoo Finance